114 related articles for article (PubMed ID: 6737077)
21. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin.
Kudo M; Todo A; Ikekubo K; Yamamoto K; Vera DR; Stadalnik RC
Hepatology; 1993 May; 17(5):814-9. PubMed ID: 8491449
[TBL] [Abstract][Full Text] [Related]
22. Tc-99m galactosyl-neoglycoalbumin hepatic scintigraphy in fulminant hepatic failure.
Moragas M; Pavía J; Ginés A; Ros D; Solá M; Huguet M; Pons F; Setoain J
Clin Nucl Med; 1995 Apr; 20(4):329-33. PubMed ID: 7788990
[TBL] [Abstract][Full Text] [Related]
23. A perspective: in vivo assay of receptor-ligand binding.
Spencer RP
J Nucl Med; 1991 Jun; 32(6):1182-3. PubMed ID: 2045932
[No Abstract] [Full Text] [Related]
24. Tc-NGA imaging in liver transplantation: preliminary clinical experience.
Woodle ES; Ward RE; Stadalnik RC; Vera DR
Surgery; 1989 Mar; 105(3):401-7. PubMed ID: 2646744
[TBL] [Abstract][Full Text] [Related]
25. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
[TBL] [Abstract][Full Text] [Related]
26. Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.
Kudo M; Vera DR; Stadalnik RC; Esquivel CO; Trudeau WL; Ikekubo K; Todo A
Dig Dis Sci; 1993 Dec; 38(12):2183-8. PubMed ID: 8261818
[TBL] [Abstract][Full Text] [Related]
27. [The preparation of 99mTc-NGA instant lyophilized kit for hepatic imaging].
Guan C; Chen Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):429-32. PubMed ID: 8150449
[TBL] [Abstract][Full Text] [Related]
28. Binding of technetium-99m to plasma proteins: influence on the distribution of Tc-99m phosphate agents.
Schümichen C; Koch K; Kraus A; Kuhlicke G; Weiler K; Wenn A; Hoffman G
J Nucl Med; 1980 Nov; 21(11):1080-5. PubMed ID: 7431108
[TBL] [Abstract][Full Text] [Related]
29. [Characterization of receptor-mediated binding of 99mTc-NGA in vitro].
Guan C; Chen Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):22-5. PubMed ID: 8070765
[TBL] [Abstract][Full Text] [Related]
30. Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.
Virgolini I; Kornek G; Höbart J; Li SR; Raolerer M; Bergmann H; Scheithauer W; Pantev T; Angelberger P; Sinzinger H
Br J Cancer; 1993 Sep; 68(3):549-54. PubMed ID: 8353045
[TBL] [Abstract][Full Text] [Related]
31. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
[TBL] [Abstract][Full Text] [Related]
32. [In vivo measurement of hepatic binding protein in chronic liver disease--validation as a measure of hepatic functional reserve].
Kudo M; Vera DR; Stadalnik RC; Trudeau WL; Ikekubo K; Todo A
Nihon Shokakibyo Gakkai Zasshi; 1991 Jan; 88(1):40-50. PubMed ID: 1851238
[TBL] [Abstract][Full Text] [Related]
33. Short circulatory residence of the hepatic binding protein.
Pessina GP; Skiftas S; Lunghetti G; Bocci V
Ital J Biochem; 1984; 33(3):149-54. PubMed ID: 6206022
[TBL] [Abstract][Full Text] [Related]
34. Differences between fluid-phase endocytosis (pinocytosis) and receptor-mediated endocytosis in isolated rat hepatocytes.
Strømhaug PE; Berg TO; Gjøen T; Seglen PO
Eur J Cell Biol; 1997 May; 73(1):28-39. PubMed ID: 9174669
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic performance of a receptor-binding radiopharmacokinetic model.
Vera DR; Stadalnik RC; Metz CE; Pimstone NR
J Nucl Med; 1996 Jan; 37(1):160-4. PubMed ID: 8543988
[TBL] [Abstract][Full Text] [Related]
36. A biological method to evaluate bifunctional chelating agents to label antibodies with metallic radionuclides.
Arano Y; Mukai T; Uezono T; Wakisaka K; Motonari H; Akizawa H; Taoka Y; Yokoyama A
J Nucl Med; 1994 May; 35(5):890-8. PubMed ID: 8176478
[TBL] [Abstract][Full Text] [Related]
37. [Estimation of hepatic functional reserve by asialoglycoprotein receptor-binding, radiolabeled synthetic ligand Tc-99m-galactosyl-neoglycoalbumin--preclinical and clinical studies].
Kudo M; Todo A; Ikekubo K; Hino M; Ito H; Yamaguchi H; Saiki Y; Yamamoto K; Yonekura Y; Torizuka K
Kaku Igaku; 1987 Nov; 24(11):1653-62. PubMed ID: 3446908
[No Abstract] [Full Text] [Related]
38. [The preparation of hepatic receptor imaging agent 99mTc-DTPA-NGA].
Li Y; Guan C; Wang Q
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):54-8. PubMed ID: 9208621
[TBL] [Abstract][Full Text] [Related]
39. Radiopharmaceutical preparation of technetium-99m-labeled galactosyl neoglycoalbumin.
Vera DR; Stadalnik RC; Kudo M; Krohn KA
Methods Enzymol; 1994; 247():402-9. PubMed ID: 7898368
[No Abstract] [Full Text] [Related]
40. From symmetrical to asymmetrical nitrido phosphino-thiol complexes: a new class of neutral mixed-ligand (99m)Tc compounds as potential brain imaging agents.
Bolzati C; Benini E; Cavazza-Ceccato M; Cazzola E; Malago E; Agostini S; Tisato F; Refosco F; Bandoli G
Bioconjug Chem; 2006; 17(2):419-28. PubMed ID: 16536474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]